Stanford University
Showing 25,301-25,350 of 34,972 Results
-
Mark Christian Reynolds
Academic Program Professional, Program-Jewett, M.
Current Role at StanfordAcademic Program Professional (School of Engineering)
-
Eman Rezk
Affiliate, Rad/Integrative Biomedical Imaging Informatics at Stanford
Visiting Postdoctoral Scholar, Rad/Integrative Biomedical Imaging Informatics at StanfordBioPostdoctoral researcher, Royal Society of Canada award recipient, and NSERC scholar, specializing in AI-driven healthcare solutions with a focus on equitable diagnostics.
-
Andrew Rezvani, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation
-
James H Rhee
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Rhee is a physiatrist and a clinical assistant professor of physical medicine and rehabilitation. For patients with spine and musculoskeletal conditions, he focuses on providing exceptional care emphasizing minimally invasive solutions designed to optimize symptom managementand patient function.
Building on his background in engineering and on his specialized medical training and experience, Dr. Rhee welcomes opportunities to combine medical, mechanical, and interpersonal approaches to the diagnosis and treatment of each patient. He offers a full range of treatment modalities, including epidural steroid injection procedures, sacroiliac and facet joint injections, trigger point and soft tissue injections, orthopedic joint injections, and more. He also provides medial branch blocks and radiofrequency ablations, and performs electrodiagnostic studies.
Among the wide range of conditions that Dr. Rhee treats are bursitis, herniated discs, radiculopathy, sciatica, spinal stenosis, spondylolisthesis, and spondylosis. He also has treated many forms of joint and muscle pain: facet joint, back, neck, hip, and sacroiliac joint pain.
Dr. Rhee’s experience encompasses short-term and long-term care for both acute and chronic conditions, including musculoskeletal injuries, spinal problems, mixed spine-neck and spine-shoulder disorders, and peripheral damage. Many of the cases he treats are injury-related, while a significant number of others are associated with aging. Another portion of his patient population presents with conditions stemming from developmental anomalies.
Prior to joining Stanford Health Care, Dr. Rhee was in private practice in the Bay Area. Previously, he also served in the US Army as a troop medical clinic officer-in-charge and as a brigade surgeon.
Dr. Rhee is board certified by the American Board of Physical Medicine and Rehabilitation. He is a fellow of the American Academy of Physical Medicine and Rehabilitation and a member of the American Society of Interventional Pain Physicians, North American Spine Society, and Spine Intervention Society. -
William Rhine
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Ko Ri, MSN, RN, FNP-C
Affiliate, IT Services
BioKo jointed Stanford Neurosurgery and Neuro IR team as a nurse practitioner in 2016. She received her bachelor degree, master of science, and post-master program in Nursing at California State University, Long Beach; and obtained Adult Acute CNS and Family Nurse Practitioner licenses. She worked with inpatients for more than 8 years including 4 years in ICU and currently coordinate the care in cerebrovascular patients.
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is advancing biomarker-driven precision medicine in breast cancer through innovative clinical trials that integrate cutting-edge therapeutics and molecular insights.
Her research focuses on circulating tumor DNA (ctDNA) to detect minimal residual disease (MRD) in early-stage breast cancer, aiming to guide personalized treatment strategies. She is also developing novel approaches to enhance immunotherapy efficacy by modulating the tumor microenvironment, including early-phase trials that combine immunotherapy with radiotherapy. As an Assistant Professor at Stanford University School of Medicine, Dr. Riaz is committed to ensuring that these next-generation therapies are accessible to all patients.. -
Toloo Riazi
Lecturer, Language Ctr
BioToloo Riazi joined Stanford University as Lecturer in September 2023. She completed her doctoral degree in Latin American Studies at University of California, Santa Barbara. She is specializing in contemporary Hispanic literature and culture. Her scholarly interests include revolutions, gender, migration, cultural and film studies.
-
Ana Trindade Ribeiro
Senior Research Data Lead, SAL Policy
Current Role at StanfordSenior Research Associate at SCALE Initiative
-
Ryan D Ribson
Assoc Sci - Chem/UFX-ray, LCLS - Linac Coherent Light Source
Current Role at StanfordI am currently an Associate Scientist in the LCLS Biological Sciences Department. I support condensed phase chemistry experiments at LCLS with a focus on hard and tender X-ray spectroscopies. I also work to develop research that applies hard and tender X-ray spectroscopic techniques to understanding enzymatic catalysis and studying ultrafast dynamics in inorganic and organic chromophores relevant for solar energy conversion and photocatalysis.
-
Anthony J. Ricci, PhD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe study hearing from biophysical, molecular and signal processing perspectives. One focus is mechanotransduction, where sound is converted into an electrical signal. As a major site for dysfunction, a more detailed understand will provide a means toward intervention. We develop new antibiotics to limit ototoxicity. We investigate drug delivery methods from surgical approaches to slow release systems, including gene therapy tools. We are studying cognitive decline following hearing loss.
